# Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial

> **NCT03790800** · PHASE3 · COMPLETED · sponsor: **The George Institute for Global Health, China** · enrollment: 2425 (actual)

## Conditions studied

- Stroke, Acute
- Cerebrovascular Disorders

## Interventions

- **DRUG:** urapidil

## Key facts

- **NCT ID:** NCT03790800
- **Lead sponsor:** The George Institute for Global Health, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-20
- **Primary completion:** 2023-11-23
- **Final completion:** 2023-11-30
- **Target enrollment:** 2425 (ACTUAL)
- **Last updated:** 2025-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03790800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03790800, "Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03790800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*